Table 3

Rates of patients in whom FPS-R improved or worsened by more than 0.5 units
Variable α-galactosidase placebo P
(N = 27) (N = 25)
Pts with difference of FPS-R score < −0.5, n (%) 14 (52%) 8 (32%) 0.15
Pts with difference of FPS-R score > 0.5, n (%) 3 (11%) 6 (24%) 0.22

Di Nardo et al.

Di Nardo et al. BMC Gastroenterology 2013 13:142   doi:10.1186/1471-230X-13-142

Open Data